Clinical variable, n (%) | CXR findings | Total N (%) | p-value | ||
---|---|---|---|---|---|
Primary endpoint pneumonia N = 18 | Other infiltrates only N = 34 | No significant pathology N = 31 | N = 83 | ||
Hospital durationa | |||||
1–5 days | 4 (22.2) | 11 (32.4) | 6 (19.4) | 21 (25.3) | 0.50 |
6–10 days | 9 (50.0) | 15 (44.1) | 16 (51.6) | 40 (48.2) | |
11–15 days | 3 (16.7) | 7 (22.6) | 6 (19.4) | 16 (19.3) | |
≥ 16 days | 1 (5.6) | 0 (0) | 3 (9.7) | 4 (4.8) | |
Clinical pneumonia diagnosisb | |||||
Fast-breathing pneumonia | 0 (0) | 5 (14.7) | 5 (16.3) | 10 (12.0) | 0.08 |
Chest-indrawing pneumonia | 5 (27.8) | 9 (26.5) | 17 (54.8) | 31 (37.3) | |
Danger sign pneumoniac | 9 (50.0) | 9 (26.5) | 7 (22.6) | 25 (30.1) | |
Treatment failure on intravenous antibiotics | 0.09 | ||||
Treatment failure on first-line intravenous antibiotics | 9 (50.0) | 9 (26.5) | 12 (38.7) | 30 (36.1) | |
Treatment failure on second-line intravenous antibiotics | 5 (27.8) | 0 (0) | 1 (3.2) | 6 (7.2) | |
Day 14 assessment | |||||
Cured at time of Day 14 visit | 11 (61.1) | 29 (85.3) | 26 (83.9) | 66 (79.5) | 0.11 |
Not cured at time of Day 14 visit | 7 (38.9) | 5 (14.7) | 5 (16.1) | 17 (20.5) |